Pages that link to "Q31116724"

The following pages link to HSV vector-delivery of GDNF in a rat model of PD: partial efficacy obscured by vector toxicity (Q31116724):

Displaying 8 items.

• GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease (Q28088320) (← links)
• Lentiviral gene transfer into the dorsal root ganglion of adult rats (Q35231284) (← links)
• The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity. (Q36015078) (← links)
• Neurotrophic factors for the treatment of Parkinson's disease. (Q37082060) (← links)
• Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery (Q37355740) (← links)
• Reversal of neurochemical changes and pain-related behavior in a model of neuropathic pain using modified lentiviral vectors expressing GDNF. (Q40310929) (← links)
• Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice (Q42382222) (← links)
• Immune responses to adeno-associated virus type 2 encoding channelrhodopsin-2 in a genetically blind rat model for gene therapy (Q45372041) (← links)